SCHEMBL7973221

SCHEMBL7973221

CCOC(=O)c1nn(C)c(-c2ccc(C)cc2)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
CYP19A1 P11511 1/20 0.50
TARBP2 Q15633 1/20 0.49
CYP2C9 P11712 3/20 0.48
CYP2C19 P33261 3/20 0.48
CYP1A2 P05177 2/20 0.48
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA9 Q16790 1/20 0.46
TRPM8 Q7Z2W7 1/20 0.45
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
ELANE P08246 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
KDM4E B2RXH2 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20075545 0.89 LMNA (0.53) ALDH1A1NPC1RAB9ACA1CA2
SCHEMBL18590178 0.83 SMN1; SMN2 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9ACYP19A1
SCHEMBL16299018 0.82 KDM4E (0.47) ALDH1A1SMN1; SMN2NPC1RAB9ACYP19A1
SCHEMBL20074995 0.77 GRM5 (0.43) ALDH1A1NPC1RAB9ALMNAGRM5
SCHEMBL5023771 0.77 CNR1 (0.55) NPC1RAB9ACYP19A1TARBP2CA1
SCHEMBL3603486 0.77 GRM5 (0.56) ALDH1A1NPC1RAB9AGABRA2GABRB2
SCHEMBL10172669 0.76 CYP19A1 (0.44) ALDH1A1SMN1; SMN2NPC1RAB9ACYP19A1
SCHEMBL23402785 0.76 GRM5 (0.39) ALDH1A1SMN1; SMN2NPC1RAB9ACYP2C9
SCHEMBL10057637 0.76 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2NPC1RAB9ACYP19A1
SCHEMBL3595225 0.75 ALDH1A1 (0.49) ALDH1A1NPC1RAB9ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed